Astrana Health (NASDAQ:ASTH) Earns Buy Rating from Analysts at Needham & Company LLC

by · The Markets Daily

Equities researchers at Needham & Company LLC initiated coverage on shares of Astrana Health (NASDAQ:ASTH – Get Free Report) in a research note issued to investors on Friday, Marketbeat.com reports. The firm set a “buy” rating and a $28.00 price target on the stock. Needham & Company LLC’s price target would suggest a potential upside of 19.30% from the company’s previous close.

ASTH has been the topic of several other research reports. BTIG Research decreased their price target on Astrana Health from $50.00 to $45.00 and set a “buy” rating on the stock in a report on Friday, November 7th. Zacks Research downgraded shares of Astrana Health from a “hold” rating to a “strong sell” rating in a research note on Monday, November 10th. Weiss Ratings reiterated a “sell (d+)” rating on shares of Astrana Health in a research note on Monday. Jefferies Financial Group reissued a “buy” rating on shares of Astrana Health in a research note on Tuesday, November 25th. Finally, Barclays decreased their price objective on shares of Astrana Health from $36.00 to $26.00 and set an “equal weight” rating for the company in a report on Monday, November 24th. Eight research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $41.33.

Check Out Our Latest Stock Report on Astrana Health

Astrana Health Trading Up 4.5%

Shares of Astrana Health stock opened at $23.47 on Friday. The company has a debt-to-equity ratio of 1.27, a quick ratio of 1.40 and a current ratio of 1.40. Astrana Health has a fifty-two week low of $20.12 and a fifty-two week high of $39.97. The company has a fifty day moving average of $26.99 and a 200 day moving average of $26.76. The company has a market capitalization of $1.32 billion, a P/E ratio of 123.53, a P/E/G ratio of 1.35 and a beta of 0.86.

Astrana Health (NASDAQ:ASTH – Get Free Report) last issued its earnings results on Wednesday, January 10th. The company reported $0.50 earnings per share (EPS) for the quarter. Astrana Health had a return on equity of 1.26% and a net margin of 0.33%.The firm had revenue of $317.00 million for the quarter. On average, sell-side analysts anticipate that Astrana Health will post 1.15 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of the company. Amalgamated Bank boosted its stake in Astrana Health by 3.4% in the third quarter. Amalgamated Bank now owns 12,325 shares of the company’s stock valued at $349,000 after acquiring an additional 409 shares in the last quarter. Thrivent Financial for Lutherans grew its position in Astrana Health by 1.5% during the 3rd quarter. Thrivent Financial for Lutherans now owns 30,977 shares of the company’s stock worth $878,000 after purchasing an additional 455 shares during the last quarter. Principal Financial Group Inc. increased its stake in Astrana Health by 0.3% during the 3rd quarter. Principal Financial Group Inc. now owns 222,985 shares of the company’s stock valued at $6,322,000 after purchasing an additional 611 shares in the last quarter. Savant Capital LLC raised its holdings in shares of Astrana Health by 2.2% in the third quarter. Savant Capital LLC now owns 30,713 shares of the company’s stock worth $871,000 after buying an additional 649 shares during the last quarter. Finally, Commonwealth of Pennsylvania Public School Empls Retrmt SYS increased its holdings in Astrana Health by 7.1% in the 2nd quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 10,657 shares of the company’s stock worth $265,000 after buying an additional 710 shares during the period. Hedge funds and other institutional investors own 52.77% of the company’s stock.

About Astrana Health

(Get Free Report)

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.

See Also